Biostatistics TRIZ Cases

Synthetic cfRNA profiles built from healthy and tumor signals train models that predict cancer status while reducing sample collection time and cost.

Dual-projection GAN training generates new MHC-binding peptides from binding and non-binding sequence data, accelerating peptide vaccine design.

Hidden-variable affinity modeling predicts antibody competition patterns from limited pairwise data, reducing epitope binning experiments and time.

Combining RNA expression features with pathology data improves tumor-of-origin classification accuracy while avoiding monolithic computational demand.

Probabilistic modeling of sparse methylation data improves lung cancer subtype detection and supports treatment selection for resistant tumors.

Reference-genome search adjusts sequencing quality scores to improve compression ratios while preserving base call confidence.

Negative-derivative melt curve clustering with difference matrices and quality filtering improves genotype calls across diverse or inconsistent assays.

A two-stage deep learning model finds novel phage-host anti-defence interactions while reducing reliance on sequence homology.

Jointly trained embedding and generative models predict protein-ligand properties without 3D structures, improving accuracy and speed.

Dual-projection GAN training generates new MHC-binding peptides from positive and non-binding sequence data to support peptide vaccine design.

Spatial fluorescence from CRP-stained tooth samples is analyzed with AI to diagnose childhood disorders without invasive sampling.

Rapid genetic sequencing and machine learning enable earlier microbial detection, growth forecasting, and smarter cleaning control in production.

Machine learning ranks guide RNA sequence and structure features to improve ADAR on-target editing specificity while limiting aberrant transcript changes.

Shared cell embedding clusters generate MOA representations and confidence scores to improve flexible, accurate perturbation MOA prediction.

By splitting optical-signal analysis between AI and calculation processing, this case cuts computational load and speeds specimen testing.

Ranks patient-specific metastasis drivers from pre/post-treatment proteomics using interaction networks and hazard ratios to guide sequential targeting.

TL1A antibodies with engineered CDRs block DR3 and DcR3 binding to suppress inflammation in autoimmune and fibrotic disease.

Combining affinity probe signals with protein length, hydrophobicity, and isoelectric point improves protein identification accuracy and quantification.

Similarity-weighted omics synthesis links cultured cell data to target tissues, improving tissue-level drug effect estimation accuracy.

Overlapping read pairs separate sequencing errors from biological variants, enabling LOWESS-based base quality correction with better accuracy in high-TMB samples.

A graph-based clinical tool standardizes gene-phenotype assertions to quickly rank relevant genes and cut manual variant review time.

Machine learning links genomic variants to haplotypes, phenotypes, and drug response to improve personalized treatment decisions.

Machine learning on cfDNA fragment sizes and end motifs improves biological age prediction and supports early pathology detection.

Graph and matrix-based phenotyping standardizes inconsistent symptom descriptions to rank likely genes quickly, even with incomplete data.

Partitioned cellular automata lattices enable trainable input, output, and processing regions for faster, lower-power image classification.

Uses 3D protein structure and amino acid property features to improve virus mutation sequence prediction beyond sequential models.

Protein analysis before and after intervention ranks metastasis-driving heterogeneous molecules to guide sequential treatment against drug resistance.

A fixed reference set guides PCA denoising of sequencing data to reduce false CNV reports caused by maternal variants.

Faced with costly patient selection, the ACBP platform combines genomic profiles and electronic records to identify responsive clinical-trial subgroups.

Dual-strand read-pair filtering and SNP-based probability modeling remove contaminated sequencing data and reduce false cancer calls.

Combines protein sequences, 3D structures, binding affinity data, and computational modeling to pinpoint ligand binding sites.

Combining HLA binding, T-cell response, and RNA expression scores ranks neoantigen epitopes for personalized immunotherapy.

Reusable compound-protein representations support ADMET and perturbation predictions with flexible models and less extensive user interaction.

Docking energy scores create pseudo-labels that expand limited TCR-peptide data for more accurate personalized medicine predictions.

Precomputed compound-protein representations support multiple bioactivity models, improving prediction accuracy and flexibility while reducing repeated data processing.